Tempest Therapeutics, Inc. (TPST)
0.511
-0.01
(-2.16%)
USD |
NASDAQ |
Oct 23, 16:00
0.5183
+0.01
(+1.43%)
After-Hours: 20:00
Tempest Therapeutics Market Cap : 8.166M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.166M |
| October 22, 2026 | 8.346M |
| October 21, 2026 | 8.440M |
| October 20, 2026 | 9.207M |
| October 19, 2026 | 9.589M |
| October 16, 2026 | 9.974M |
| October 15, 2026 | 10.15M |
| October 14, 2026 | 10.15M |
| October 13, 2026 | 10.89M |
| October 12, 2026 | 11.87M |
| October 09, 2026 | 12.15M |
| October 08, 2026 | 12.30M |
| October 07, 2026 | 12.65M |
| October 06, 2026 | 12.58M |
| October 05, 2026 | 12.67M |
| October 02, 2026 | 12.96M |
| October 01, 2026 | 12.88M |
| September 30, 2026 | 13.33M |
| September 29, 2026 | 12.95M |
| September 28, 2026 | 13.29M |
| September 25, 2026 | 13.25M |
| September 24, 2026 | 13.58M |
| September 23, 2026 | 14.73M |
| September 22, 2026 | 15.98M |
| September 21, 2026 | 12.36M |
| Date | Value |
|---|---|
| September 18, 2026 | 15.47M |
| September 17, 2026 | 14.30M |
| September 16, 2026 | 19.34M |
| September 15, 2026 | 12.07M |
| September 14, 2026 | 12.53M |
| September 11, 2026 | 12.97M |
| September 10, 2026 | 12.83M |
| September 09, 2026 | 14.52M |
| September 08, 2026 | 15.77M |
| September 04, 2026 | 16.46M |
| September 03, 2026 | 16.78M |
| September 02, 2026 | 17.58M |
| September 01, 2026 | 16.78M |
| August 31, 2026 | 17.42M |
| August 28, 2026 | 16.94M |
| August 27, 2026 | 17.26M |
| August 26, 2026 | 17.26M |
| August 25, 2026 | 17.74M |
| August 24, 2026 | 17.58M |
| August 21, 2026 | 16.62M |
| August 20, 2026 | 16.30M |
| August 19, 2026 | 17.10M |
| August 18, 2026 | 17.10M |
| August 17, 2026 | 18.06M |
| August 14, 2026 | 16.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price | 0.511 |
| Earnings Yield | -877.7% |